Trellis Bioscience Overview
- Year Founded
-
1998
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$38.3M
- Investors
-
8
Trellis Bioscience General Information
Description
Operator of a biotechnology company intended to leverage proprietary cellSpot technology to derive rare, naturally optimized antibodies from healthy donor blood against infectious diseases and cancer. The company's platform derives therapeutic antibodies directly from the human immune system to optimize human-derived antibodies against bacterial and viral infectious diseases, as well as cancer, enabling clients to get access to alternatives when the immune system attacks protein therapeutics, providing patients with safe and effective medical care.
Contact Information
Website
www.trellisbio.comCorporate Office
- 702 Marshall Street
- Suite 301
- Redwood City, CA 94063
- United States
Corporate Office
- 702 Marshall Street
- Suite 301
- Redwood City, CA 94063
- United States
Trellis Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 22. Later Stage VC (Series C) | 16-Jul-2026 | $38.3M | Completed | Generating Revenue | ||
| 21. Secondary Transaction - Private | 23-Jun-2022 | Completed | Generating Revenue | |||
| 20. Grant | 01-Sep-2020 | Completed | Generating Revenue | |||
| 19. Grant | 13-Jan-2020 | Completed | Generating Revenue | |||
| 18. Later Stage VC (Series B) | 01-Jan-2019 | Completed | Generating Revenue | |||
| 17. Debt - General | Completed | Generating Revenue | ||||
| 16. Grant | 01-Jul-2014 | Completed | Generating Revenue | |||
| 15. Grant | 16-Aug-2012 | Completed | Generating Revenue | |||
| 14. Debt - General | 08-Nov-2011 | $235K | $49.1M | Completed | Generating Revenue | |
| 13. Grant | 31-Aug-2011 | $48.8M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Trellis Bioscience Patents
Trellis Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4363456-A1 | Anti-alk antibodies & uses thereof | Inactive | 28-Jun-2021 | ||
| EP-4363456-A4 | Anti-alk antibodies & uses thereof | Inactive | 28-Jun-2021 | ||
| WO-2023278341-A1 | Anti-alk antibodies & uses thereof | Inactive | 28-Jun-2021 | ||
| US-20240254258-A1 | Anti-alk antibodies and uses thereof | Pending | 28-Jun-2021 | ||
| US-20240131508-A1 | Diagnostics for emerging disease | Pending | 27-Apr-2021 | B01L3/502707 |
Trellis Bioscience Signals
Trellis Bioscience Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AMR Action Fund | Impact Investing | Minority | ||
| National Institutes of Health | Government | |||
| CARB-X | University | |||
| K2X | Venture Capital | Minority | ||
| Nodenza Venture Partners | Venture Capital | Minority |
Trellis Bioscience Acquisitions (1)
Trellis Bioscience’s most recent deal was a Merger/Acquisition with A-CUBE (Discovery Tools (Healthcare)). The deal was made on 01-Jan-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| A-CUBE (Discovery Tools (Healthcare)) | 01-Jan-2013 | Merger/Acquisition | Discovery Tools (Healthcare) |
Trellis Bioscience FAQs
-
When was Trellis Bioscience founded?
Trellis Bioscience was founded in 1998.
-
Where is Trellis Bioscience headquartered?
Trellis Bioscience is headquartered in Redwood City, CA.
-
What is the size of Trellis Bioscience?
Trellis Bioscience has 15 total employees.
-
What industry is Trellis Bioscience in?
Trellis Bioscience’s primary industry is Biotechnology.
-
Is Trellis Bioscience a private or public company?
Trellis Bioscience is a Private company.
-
What is Trellis Bioscience’s current revenue?
The current revenue for Trellis Bioscience is .
-
How much funding has Trellis Bioscience raised over time?
Trellis Bioscience has raised $87.4M.
-
Who are Trellis Bioscience’s investors?
AMR Action Fund, National Institutes of Health, CARB-X, K2X, and Nodenza Venture Partners are 5 of 8 investors who have invested in Trellis Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process